NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Evidium

Evidium

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.evidium.com/

Last Round

Series A

Nov 10, 2025

Total Funding Raised

$22M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Evidium is a healthcare technology company that provides a neurosymbolic AI platform to transform clinical knowledge into computational models for care delivery and insurance environments.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Business Intelligence, InsurTech

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

medical AIhealthcare analyticsclinical decision supportclinical intelligencepredictive healthcareprobabilistic forecastingexplainable AIcost modelingclinical modelingrisk adjustmentSaaShealth informaticspayvider solutionspatient journey mappingblack-box AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evidium Comps

Public and private peers based on sector, stage, and business model.

Evidium comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Evidium Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 10, 2025

Key People

Founding team and executive leadership

Carl Bate

Founder CEO

Founding Team

Sean Thomas

Chief Product Officer

Executive Team

Evidium Investors

Notable investors and investment history

Evidium investors
InvestorRounds
Health2047Series A
Interwoven VenturesSeries A
WGG PartnersSeries A
Mindset VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Developing a computational medical intelligence layer for healthcare.

Evidium Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Evidium Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Evidium's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range33
Year Founded2021
Last FundingNov 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.